0001209191-22-005556.txt : 20220131 0001209191-22-005556.hdr.sgml : 20220131 20220131160012 ACCESSION NUMBER: 0001209191-22-005556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220127 FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BREITMEYER JAMES B CENTRAL INDEX KEY: 0001244823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 22573898 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-27 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001244823 BREITMEYER JAMES B 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2022-01-27 4 P 0 25000 1.6832 A 46544 I By Family Trust Common Stock 384149 D Common Stock 6493 I By Spouse Common Stock 733 I By Child The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.85. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above. This Form 4 corrects the number of RSUs awarded on January 3, 2022 held by the Reporting Person's spouse erroneously reported as 6,793 due to clerical error. /s/Chase C. Leavitt, Attorney-in-fact 2022-01-31